SBC Medical Group Holdings (SBC) Emerging Growth Conference 2025 summary
Event summary combining transcript, slides, and related documents.
Emerging Growth Conference 2025 summary
17 Dec, 2025Conference overview
The event was the 86th Emerging Growth Conference, featuring virtual presentations and Q&A sessions with investors.
SBC Medical Group Holdings presented recent performance, business progress, and capital initiatives.
The company operates 259 clinics, with recent expansion through the addition of Jenn Clinic and MB Career Lounge.
Presentations were accessible via webcast, with opportunities for live questions from attendees.
Business performance and strategy
Revenue declined 18% year-on-year due to strategic restructuring, franchise fee revisions, and increased point redemptions.
The company exited staffing services and deconsolidated affiliates to focus on core growth areas.
Procurement and rental revenue increased, driven by higher medical material purchases and device upgrades.
High-growth areas include dermatological aesthetic medicine, orthopedics, and AGA treatment.
Multi-brand strategy and new clinic launches (Neo Skin Clinic, Jenn Clinic) are key growth drivers.
Global expansion and initiatives
Medical tourism is being strengthened, targeting Chinese tourists with enhanced marketing and interpreter support.
Expansion in Southeast Asia includes Japanese language services in Singapore following the AHH acquisition.
U.S. operations enhanced by appointing Dr. Steven Cohen as advisor and hiring experienced executives for global strategy and marketing.
The company maintains a robust financial base, supporting organic growth and M&A opportunities.
Latest events from SBC Medical Group Holdings
- Global expansion and financial recovery set the stage for 20%+ international revenue growth.SBC
Emerging Growth Conference 8922 Jan 2026 - Recovery in Japan and global expansion via OrangeTwist partnership drive future growth.SBC
Sidoti Micro-Cap Virtual Investor Conference22 Jan 2026 - Franchise-based cosmetic clinic operator registers $50M equity and 99M shares for resale; CEO retains control.SBC
Registration Filing29 Dec 2025 - Revenue and net income up, with franchise and global growth offsetting Q4 decline.SBC
Q4 202426 Dec 2025 - Growth driven by multi-brand clinics, global expansion, and strategic pricing amid market normalization.SBC
Emerging Growth Conference 8125 Dec 2025 - Franchise growth, global expansion, and R&D drive recovery and future performance.SBC
Emerging Growth Conference 8812 Dec 2025 - Rebounding after restructuring, the group targets 10%-15% growth in 2026 via expansion and R&D.SBC
Sidoti's Year End Virtual Investor Conference12 Dec 2025 - Pono Capital Two and SBC Medical Group to merge; Dr. Aikawa leads, SBC holders to own 80%+ post-merger.SBC
Proxy Filing2 Dec 2025 - Pono Capital Two merges with SBC Medical, forming a Nasdaq firm with Dr. Aikawa holding 81.4% voting power.SBC
Proxy Filing2 Dec 2025